Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria
Open Access
- 7 March 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3), e0173286
- https://doi.org/10.1371/journal.pone.0173286
Abstract
Acute kidney injury (AKI) remains a treatment-limiting toxicity of colistin. Recently developed clinical practice guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) group have harmonized definitions of AKI, but have not been widely applied to patients receiving colistin. We retrospectively defined AKI by KDIGO definitions among adult patients receiving intravenous colistin for ≥ 3 days. Risk factors for AKI within 48 hours and 7 days of initiating colistin were determined by multivariable logistic regression. Among 249 patients treated with colistin, rates of AKI were 12% and 29% at 48 hours and 7 days, respectively. At 48 hours, patients in the intensive care unit were at increased risk for AKI. Within 7 days, colistin daily doses >5mg/kg, chronic liver disease, and concomitant vancomycin were independent predictors. Seven percent of patients required renal replacement therapy at a median of 5 days (range: 3–7) following colistin initiation. Safe use of colistin is promoted by early detection of AKI with KDIGO criteria, avoiding nephrotoxins, and limiting duration of therapy.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (K08AI114883)
This publication has 35 references indexed in Scilit:
- Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative PneumoniaJournal of Intensive Care Medicine, 2016
- Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort StudyClinical Infectious Diseases, 2015
- A review on colistin nephrotoxicityEuropean Journal of Clinical Pharmacology, 2015
- Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving ColistinAntimicrobial Agents and Chemotherapy, 2014
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney InjuryAmerican Journal of Kidney Diseases, 2013
- Nephrotoxicity Associated with Intravenous Colistin in Critically Ill PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of PatientsAntimicrobial Agents and Chemotherapy, 2011
- Colistin Dosing and Nephrotoxicity in a Large Community Teaching HospitalAntimicrobial Agents and Chemotherapy, 2010
- Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with ColistinNephron Clinical Practice, 2010
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005